- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07624825
Emotional Awareness Therapy Study (TREAT)
A Feasibility Study Exploring Emotional Health Training After Moderate to Severe Traumatic Brain Injury
The purpose of this study is to learn about the potential benefits of two different training programs in helping improve emotional health and well-being in people who have had a traumatic brain injury.
Participants will be assigned to one of two programs based on the time since their injury. One of the programs will teach participants how to recognize and label emotions; the other will teach healthy ways of living. Participants may improve their emotional well-being and contribute to the knowledge needed to achieve better emotional health outcomes for people with TBI.
For eligible participants, the study includes 4 assessments. Assessments may take 30-60 minutes and will be done using secure videoconferencing, phone calls, and/or electronic surveys. The first assessment will ask questions about demographics, the participant's brain injury, and some medical history. All assessments will include questions about emotions, emotional awareness, resilience, loneliness, and how participants manage emotions, in addition to broader wellness questions and questions about how participants interact with others.
Regardless of the program, the training includes 8 one-on-one sessions with a trained staff member over the course of about 1 month. Each session will last approximately 60-90 minutes. These sessions will start shortly after completing the first assessment. Preferably, participants will complete 1-2 training sessions a week, depending on availability and preference. These sessions will include education, discussion, and practice exercises.
After the program is finished, participants will be asked to complete the same surveys completed at baseline for three follow-up time points (immediately following the program, 3 months after the program, and 6 months after). Total participation in the study will last approximately 8 months.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Grace Wells, BS
- Telefonnummer: 68682 732-321-7000
- E-post: grace.wells1@hmhn.org
Studieorter
-
-
New Jersey
-
Edison, New Jersey, Förenta staterna, 08820
- Rekrytering
- Hackensack Meridian Health - JFK Johnson Rehabilitation Institute
-
Huvudutredare:
- Dawn Neumann, PhD, FACRM
-
Kontakt:
- Grace Wells, BS
- Telefonnummer: 68682 732-321-7000
- E-post: grace.wells1@hmhn.org
-
Kontakt:
- Sarah Enock, BS
- Telefonnummer: 848-893-6577
- E-post: tbiresearchjfkjri@hmhn.org
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Moderate or Severe TBI
- ≥18 years old
- ≥6 months post-TBI
- Speaks and understands English
- Medications that can influence mood should be stable (6+ weeks)
- Elevated alexithymia
- Demonstrate an understanding of the study and their rights (e.g. ability to answer the following questions correctly after a review of the study details during pre-screening process)
Exclusion Criteria:
- Premorbid neurological disorder other than TBI
- Degenerative neurologic condition
- Active or uncontrolled major psychiatric disorder
- Conditions that pose safety concern to self or others, such as suicide risk
- Visual, hearing, communication, or cognitive impairments that would impede participation
- Active involvement in an intensive rehabilitation program
- Individuals who recently started psychotherapy and/or mental health counseling
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: TREAT-A
Eight lessons delivered by a trained team member (interventionist) to the participant over ~4 weeks.
It involves psycho-educational lessons and skill-building exercises to achieve the following objectives based on the characteristics of alexithymia.: 1) learn benefits of emotional awareness; 2) improve threshold for earlier detection of emotional responses; 3) label and differentiate emotions; 4) experience range of emotions; and 5) distinguish emotions from thoughts, actions and sensations.
|
The TREAT-A program will teach participants how to recognize, label, and differentiate their emotions.
The program will cover ways to reduce feeling "confused" or numb, and decrease the feelings of anger, stress and being overwhelmed.
|
|
Aktiv komparator: TREAT-B
Provides education on TBI and overall brain health through instructional sessions, discussion, and structured tasks geared towards living healthy and improving general well-being.
|
The TREAT-B program will teach participants strategies to improve their overall brain health and functioning.
It will also teach participants how to develop and work towards individualized short-term and long-term goals aimed at improving their quality of life.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Ineligibility and Attrition Rates
Tidsram: Through study completion, an average of 8 months
|
Data will be tracked on the number of individuals who were ineligible (and reasons for ineligibility) as well as withdrawals (reasons for withdrawal) and /or number of participants who become "lost" (no longer able to contact).
|
Through study completion, an average of 8 months
|
|
Satisfaction Survey and Interview
Tidsram: immediate post-treatment
|
Range: Min/ Max = 1 to 5 Lower scores are worse; higher scores are more satisfied
|
immediate post-treatment
|
|
Interventionist Evaluation of Session Participation
Tidsram: intervention training sessions 1-8 (approximately 8 months)
|
Range: Min/Max = 6 to 24 Internal assessment completed by the interventionist at the end of each training session.
|
intervention training sessions 1-8 (approximately 8 months)
|
|
Patient Global Impression of Change (PGIC) emotional functioning and quality of life
Tidsram: immediate post-treatment
|
Range: Min/ Max = 1 to 7 Lower scores are worse; higher scores are better.
|
immediate post-treatment
|
|
Care-partner Global Impression of Change (CGIC) emotional functioning and quality of life
Tidsram: immediate post-treatment
|
Range: Min/ Max = 1 to 7 Lower scores are worse; higher scores are better.
|
immediate post-treatment
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Toronto Alexithymia Scale-20
Tidsram: 1) baseline 2) immediate post-treatment, 3) 3 months post-treatment; 4) 6- months post-treatment.
|
Range: Min/ Max = 20 to 100 Lower scores indicate less alexithymia (good); higher scores indicate greater alexithymia (bad)
|
1) baseline 2) immediate post-treatment, 3) 3 months post-treatment; 4) 6- months post-treatment.
|
|
Difficulty with Emotion Regulation Scale (DERS; Co-Primary outcome)
Tidsram: 1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
|
Range: Min/ Max = 36 to 180 Lower scores indicate less dysregulation (good); higher scores indicate more dysregulation (bad)
|
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
|
|
Brief Resilience Scale
Tidsram: 1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
|
Range: Min/ Max = 6 to 30 Lower scores indicate worse resilience; higher scores indicate better resilience
|
1) baseline 2) immediate post-treatment, 3) 3 months; 4) 6- months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Dawn Neumann, PhD, FACRM, Hackensack Meridian Health
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Pro2026-0081
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .